CTXR
Citius Pharmaceuticals Inc
NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY
$0.70
+16.96% today
Updated 2026-04-30
Market cap
$17.23M
P/E ratio
—
P/S ratio
4.37x
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
Citius Pharmaceuticals Inc (CTXR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-156.7%
Last 4 quarters
Revenue YoY growth
+2429.5%
Most recent quarter
EPS YoY growth
+70.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-15.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-23.8%
2025-12-23
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-13 | $-0.38 | -26.7% | $0.79 | $0.74 | -6.5% |
| 2025-12-23 | $-0.46 | -1020.0% | $1.05 | $0.80 | -23.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.30 | $-0.38 | -26.7% | $3.94M | +2429.5% |
| 2025-09-30 | $0.05 | $-0.46 | -1020.0% | — | — |
| 2025-06-30 | $0.05 | $-0.80 | -1700.0% | — | — |
| 2025-03-31 | $0.11 | $-1.27 | -1254.5% | — | — |
| 2024-12-31 | $-1.25 | $-1.30 | -4.0% | $155926.00 | — |
| 2024-09-30 | $-0.04 | $-1.59 | -3872.5% | $155926.00 | — |
| 2024-06-30 | $-0.05 | $-0.06 | -20.0% | — | — |
| 2024-03-31 | $-0.06 | $-0.05 | +16.7% | — | — |
| 2023-12-31 | $0.13 | $-0.06 | -146.2% | — | — |
| 2023-09-30 | $-0.02 | $-0.08 | -300.0% | — | — |
| 2023-06-30 | $-0.05 | $-0.06 | -20.0% | — | — |
| 2023-03-31 | $-0.04 | $-0.07 | -75.0% | — | — |
Frequently asked questions
Has Citius Pharmaceuticals Inc beaten earnings estimates?
Citius Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -156.7% over the last 4 quarters.
How does CTXR stock react to earnings?
CTXR stock has moved an average of -15.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Citius Pharmaceuticals Inc's revenue growth rate?
Citius Pharmaceuticals Inc reported year-over-year revenue growth of +2429.5% in its most recent quarter, with EPS growing +70.8% year-over-year.